CEO Evan Feinberg (Boris Feldman)

December 2, 2020 07:24 AM ESTUpdated December 3, 12:29 PM

A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline

Jason Mast

Editor

Evan Feinberg could have picked a better time to launch his AI biotech, Genesis. He announced a $4.1 million round last November; by March …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER

TRENDING NOW

Big leases, bigger regrets: Biotech slump turns swanky offices from asset into liability

Altos Labs buys anti-aging startup Dorian Therapeutics

Genentech expands deal with molecular glue biotech Orionis for $105M upfront

Cocaine vaccine, a longshot attempt to quell cravings, yields mixed data in small study

Updated: Trump administration reveals 'most favored nation' drug price country targets

sponsored

Does your supply chain hold up under pressure for high-risk temperature-critical shipments?